Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery

Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell... Clin Transl Oncol (2017) 19:1091–1098 DOI 10.1007/s12094-017-1643-0 RESEARCH AR TIC L E Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery 1 1 2 3 1 1 1 • • • • • • • Y. He H. Li Y. Chen P. Li L. Gao Y. Zheng Y. Sun 1 4 J. Chen X. Qian Received: 27 September 2016 / Accepted: 2 March 2017 / Published online: 15 March 2017 Federacio ´ n de Sociedades Espan ˜ olas de Oncologı ´a (FESEO) 2017 Abstract overexpression was correlated with the high expression of Purpose Anoctamin 1 (ANO1), a recently identified cal- EGFR and led to an advanced tumor stage. And also high cium-activated chloride channel, has been found to have a ANO1 expression was significantly correlated with high critical role in tumorigenesis and tumor progression in recurrence rate at 1-year follow-up. several types of cancer. However, its role in non-small cell Conclusions ANO1 overexpression associated with the lung cancer (NSCLC) remains to be elucidated. In this high expression of EGFR can be a predictive marker of study, we evaluated the utility of ANO1 as a prognostic recurrence http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical and Translational Oncology Springer Journals

Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery

Loading next page...
 
/lp/springer_journal/expression-of-anoctamin-1-is-associated-with-advanced-tumor-stage-in-y1buPZSQI4
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Federación de Sociedades Españolas de Oncología (FESEO)
Subject
Medicine & Public Health; Oncology
ISSN
1699-048X
eISSN
1699-3055
D.O.I.
10.1007/s12094-017-1643-0
Publisher site
See Article on Publisher Site

Abstract

Clin Transl Oncol (2017) 19:1091–1098 DOI 10.1007/s12094-017-1643-0 RESEARCH AR TIC L E Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery 1 1 2 3 1 1 1 • • • • • • • Y. He H. Li Y. Chen P. Li L. Gao Y. Zheng Y. Sun 1 4 J. Chen X. Qian Received: 27 September 2016 / Accepted: 2 March 2017 / Published online: 15 March 2017 Federacio ´ n de Sociedades Espan ˜ olas de Oncologı ´a (FESEO) 2017 Abstract overexpression was correlated with the high expression of Purpose Anoctamin 1 (ANO1), a recently identified cal- EGFR and led to an advanced tumor stage. And also high cium-activated chloride channel, has been found to have a ANO1 expression was significantly correlated with high critical role in tumorigenesis and tumor progression in recurrence rate at 1-year follow-up. several types of cancer. However, its role in non-small cell Conclusions ANO1 overexpression associated with the lung cancer (NSCLC) remains to be elucidated. In this high expression of EGFR can be a predictive marker of study, we evaluated the utility of ANO1 as a prognostic recurrence

Journal

Clinical and Translational OncologySpringer Journals

Published: Mar 15, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off